Grants for Public and State controlled institutions of higher education - Health

This funding opportunity supports U.S.-based healthcare organizations working with maternal care professionals to create culturally relevant educational materials and tools that improve access to maternal immunization resources, particularly in underserved communities.

This funding opportunity supports researchers and institutions conducting clinical trials and studies to improve stroke treatment, recovery, and prevention through collaboration within a national network.

This grant provides funding to organizations in Minnesota to strengthen infection prevention and control practices in long-term care facilities serving older adults, particularly in rural areas.

This grant provides funding for dentists in NIH postdoctoral research positions to transition to independent research roles at academic institutions, supporting their development as new investigators.

This funding opportunity supports higher education institutions and nonprofit organizations in developing educational programs that promote diversity and encourage individuals from underrepresented backgrounds to pursue careers in biomedical and behavioral research.

The grant titled "Mechanistic and Hemodynamic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01 - Clinical Trial Not Allowed)" aims to fund research into the biological causes, progression, and effects of diffuse white matter disease, a common age-related brain condition linked to cognitive impairment and dementia, with the ultimate goal of reducing its impact on health.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and the National Institute of Neurological Disorders and Stroke (NINDS), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and National Heart, Lung and Blood Institute (NHLBI), intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs). These Centers promote collaborative basic, translational, and clinical research and provide important resources that can be used by the national muscular dystrophy research communities. The Centers also provide outstanding environments for the training of new researchers capable of addressing high priority objectives in muscular dystrophy research. Center investigators are expected to participate in important community outreach efforts to increase awareness of their research activities among people with lived experience and the related advocacy communities and to incorporate community perspectives into the conduct of patient-centered research. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. Only New and Renewal applications will be eligible. This NOFO will utilize the P50 activity code. Details of the planned NOFO are provided below.

This funding opportunity supports innovative interdisciplinary research projects that leverage artificial intelligence and advanced data science to improve human health and healthcare systems, targeting accredited U.S. educational institutions and non-profit organizations.

This funding opportunity provides financial support to local nonprofits, educational institutions, and government entities in Michigan's Upper Peninsula to implement community health initiatives that improve wellness and access to health services.

This program provides financial support to food retailers in underserved communities to improve access to healthy food options for low- and moderate-income populations.

This grant supports licensed neurologists and neurosurgeons in the NINDS intramural program to transition to independent academic faculty positions while leading clinical trials and advancing their research careers.

This funding opportunity supports innovative projects that develop new technologies for recording and modulating brain activity, aimed at advancing research on central nervous system diseases and disorders.

This grant provides funding to charitable organizations that serve the community in Alleghany County, North Carolina, to address local needs and improve residents' quality of life.

This grant provides funding for researchers at U.S. institutions to develop and evaluate innovative strategies that improve access to mental health care for children and adolescents, particularly in underserved communities.

This funding opportunity aims to establish a central hub for training and career development in kidney, urologic, and hematologic disease research, inviting a wide range of organizations to enhance collaboration and mentorship in these fields.

This funding opportunity supports a wide range of organizations in developing innovative tools to measure how psychiatric medications impact the brains of adolescents, ultimately aiming to improve treatment options for young people with mental health conditions.

This funding opportunity supports research aimed at understanding how HIV-related changes in the immune system affect the risk of tuberculosis and hepatitis B in individuals undergoing treatment, encouraging innovative approaches and collaboration among diverse research teams.

This funding opportunity supports charitable organizations and government entities that provide programs for at-risk and underserved youth in the Augusta Judicial Circuit, focusing on education, mentoring, health, and self-sufficiency.

This funding opportunity supports innovative early-stage neuroscience research projects that aim to advance our understanding of neurological disorders and mental health, targeting a wide range of eligible applicants including universities, nonprofits, and small businesses.

This funding opportunity supports diverse organizations in conducting innovative research to better understand and address cardiovascular disease in individuals with type 1 diabetes.